After extensive conversations
over the
past several weeks with senior staff persons and key Members of Congress who serve on the congressional committees with jurisdiction
over the bill, it has become clear that very few, if any, public health bills such as the SMA Treatment Acceleration Act will move
through Congress during the lame - duck session set to begin on November 15.